tiprankstipranks
Trending News
More News >
Carisma Therapeutics, Inc. (GB:0IFZ)
:0IFZ
UK Market

Carisma Therapeutics (0IFZ) Stock Investors

Compare
0 Followers
Based on 803,756 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GB:0IFZ
On average, investors allocate 1.60% of their portfolios to GB:0IFZ
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 803,756 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding 0IFZ

0.5%
Last 7
Days
6.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GB:0IFZ, out of 803,756 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

0IFZ Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of investors who made their portfolios public
The table shows changes in 0IFZ in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

0IFZ Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Lucid Group
5.15%
-0.45%
-0.11%
6.59B
Consumer Cyclical
Nio
7.86%
-0.69%
-2.54%
7.50B
Consumer Cyclical
DraftKings
4.29%
+2.62%
+4.80%
33.69B
Consumer Cyclical
Riot Platforms
4.61%
-0.14%
-1.39%
3.65B
Financial
Marathon Digital Holdings
4.92%
-0.46%
-2.23%
5.57B
Financial
Viking Therapeutics
3.75%
-0.75%
-3.16%
3.25B
Healthcare
Block
3.46%
-0.69%
-3.15%
39.40B
Technology
Ford Motor
5.38%
-0.60%
-2.52%
41.87B
Consumer Cyclical
JD
4.50%
-0.44%
-0.76%
52.65B
Consumer Cyclical
Delta Air Lines
4.50%
-0.74%
-2.40%
31.92B
Industrials
Based on the activity of 803,756 active portfolios
Open your Smart Portfolio

0IFZ Investor Analysis

GB:0IFZ investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
13.2%
of GB:0IFZ holders
are under 35
Average Segment Performance
Average P/E Ratio20.53
Beta4.60
Dividend Yield4.09%
GB:0IFZ investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
53.2%
of GB:0IFZ holders
are between 35–55
Average Segment Performance
Average P/E Ratio15.79
Beta11.42
Dividend Yield3.52%
GB:0IFZ investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
33.6%
of GB:0IFZ holders
are over 55
Average Segment Performance
Average P/E Ratio13.92
Beta3.72
Dividend Yield3.81%
Overview of age group and performance of GB:0IFZ stock investors
See who invests in 0IFZ according to age group and performance.

FAQ

How many retail Investors hold GB:0IFZ?
<0.1% of TipRanks' retail investors hold GB:0IFZ in their portfolios.
    What is GB:0IFZ Investor Sentiment?
    GB:0IFZ’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of GB:0IFZ in the last 7 days?
      ▲ 0.5% of TipRanks' retail investors changed their holding of GB:0IFZ in the last 7 days.
        What percentage of retail investors changed their holding of GB:0IFZ in the last 30 days?
        ▼ 6.0% of TipRanks' retail investors changed their holding of GB:0IFZ in the last 30 days.
          What is the average age of retail investors who hold GB:0IFZ?
          The average age of GB:0IFZ Holders is between 35–55.
            What other stocks have GB:0IFZ investors also bought?
            GB:0IFZ Investors also bought LCID, NIO, DKNG, RIOT, MARA, VKTX, XYZ, F, JD, DAL.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis